Tilray, Inc. TLRY is scheduled to release second-quarter 2019 results on Aug 13.
In the last reported quarter, the company missed earnings expectations by 8%. The track record has been pretty disappointing for this company, which went public in July 2018. In the last four quarters, the company missed earnings estimates thrice with average negative surprise of 40.29%.
Let us see what is in store for the second quarter.
Pipeline Progress in Focus
Tilray produces medical cannabis in Canada and Europe. The company has two product categories — dried cannabis, which includes whole flower and ground flower, and cannabis extracts, which includes full-spectrum and purified oil drops and capsules.
There is a global paradigm shift regarding cannabis. Medical cannabis